erythrosine has been researched along with Brain Neoplasms in 31 studies
Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.
Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Glioblastoma (GBM) has poor survival rate and uniformly acquired chemoresistance to its frontline agent, Temozolomide (TMZ)." | 7.81 | Temozolomide competes for P-glycoprotein and contributes to chemoresistance in glioblastoma cells. ( Munoz, JL; Rameshwar, P; Scotto, KW; Walker, ND, 2015) |
| " Such effects should be kept in mind when acyl-derived compounds are used to probe the function of the endocannabinoid system in the CNS, particularly in chronic administration protocols." | 5.33 | Acyl-based anandamide uptake inhibitors cause rapid toxicity to C6 glioma cells at pharmacologically relevant concentrations. ( De Lago, E; Fernández-Ruiz, J; Fowler, CJ; Gustafsson, SB; Jacobsson, SO; Nilsson, J, 2006) |
| "Total resection is the optimal treatment for malignant gliomas." | 5.30 | Experimental and clinical study of detection of glioma at surgery using fluorescent imaging by a surgical microscope after fluorescein administration. ( Ishii, H; Kabuto, M; Kitai, R; Kobayashi, H; Kodera, T; Kubota, T; Nakagawa, T; Takeuchi, H, 1997) |
| " Glioblastoma (GBM) has poor survival rate and uniformly acquired chemoresistance to its frontline agent, Temozolomide (TMZ)." | 3.81 | Temozolomide competes for P-glycoprotein and contributes to chemoresistance in glioblastoma cells. ( Munoz, JL; Rameshwar, P; Scotto, KW; Walker, ND, 2015) |
| "85 mL/h), and a long elimination half-life (mean T(1/2;β) = 307 hours)." | 2.76 | Pharmacokinetics of 5-aminofluorescein-albumin, a novel fluorescence marker of brain tumors during surgery. ( Ding, R; Fardanesh, M; Frei, E; Haefeli, WE; Kremer, P; Schrenk, HH, 2011) |
| " Such effects should be kept in mind when acyl-derived compounds are used to probe the function of the endocannabinoid system in the CNS, particularly in chronic administration protocols." | 1.33 | Acyl-based anandamide uptake inhibitors cause rapid toxicity to C6 glioma cells at pharmacologically relevant concentrations. ( De Lago, E; Fernández-Ruiz, J; Fowler, CJ; Gustafsson, SB; Jacobsson, SO; Nilsson, J, 2006) |
| "Total resection is the optimal treatment for malignant gliomas." | 1.30 | Experimental and clinical study of detection of glioma at surgery using fluorescent imaging by a surgical microscope after fluorescein administration. ( Ishii, H; Kabuto, M; Kitai, R; Kobayashi, H; Kodera, T; Kubota, T; Nakagawa, T; Takeuchi, H, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (54.84) | 18.7374 |
| 1990's | 4 (12.90) | 18.2507 |
| 2000's | 3 (9.68) | 29.6817 |
| 2010's | 6 (19.35) | 24.3611 |
| 2020's | 1 (3.23) | 2.80 |
| Authors | Studies |
|---|---|
| Ozden, M | 1 |
| Mammadkhanli, O | 1 |
| Zaimoglu, M | 1 |
| Bayatli, E | 1 |
| Bozkurt, M | 1 |
| Gielen, PR | 1 |
| Aftab, Q | 1 |
| Ma, N | 1 |
| Chen, VC | 1 |
| Hong, X | 1 |
| Lozinsky, S | 1 |
| Naus, CC | 1 |
| Sin, WC | 1 |
| Munoz, JL | 1 |
| Walker, ND | 1 |
| Scotto, KW | 1 |
| Rameshwar, P | 1 |
| Wu, HB | 1 |
| Wang, Z | 1 |
| Wang, QS | 1 |
| Han, YJ | 1 |
| Wang, M | 1 |
| Zhou, WL | 1 |
| Li, HS | 1 |
| Kremer, P | 2 |
| Fardanesh, M | 2 |
| Ding, R | 2 |
| Pritsch, M | 1 |
| Zoubaa, S | 1 |
| Frei, E | 2 |
| Schrenk, HH | 1 |
| Haefeli, WE | 1 |
| Deleyrolle, LP | 2 |
| Harding, A | 1 |
| Cato, K | 1 |
| Siebzehnrubl, FA | 1 |
| Rahman, M | 1 |
| Azari, H | 2 |
| Olson, S | 1 |
| Gabrielli, B | 1 |
| Osborne, G | 1 |
| Vescovi, A | 1 |
| Reynolds, BA | 2 |
| Rohaus, MR | 1 |
| Fortin, JM | 1 |
| SEAMAN, WB | 1 |
| TER-POGOSSIAN, MM | 1 |
| SCHWARTZ, HG | 1 |
| YANO, K | 1 |
| ULITOVSKII, DA | 1 |
| ORTIZBERROCAL, J | 1 |
| De Lago, E | 1 |
| Gustafsson, SB | 1 |
| Fernández-Ruiz, J | 1 |
| Nilsson, J | 1 |
| Jacobsson, SO | 1 |
| Fowler, CJ | 1 |
| Yoshii, Y | 1 |
| Maki, Y | 1 |
| Egashira, T | 1 |
| Nakagawa, K | 1 |
| Reck, R | 1 |
| Wissen-Siegert, I | 1 |
| Kabuto, M | 1 |
| Kubota, T | 1 |
| Kobayashi, H | 1 |
| Nakagawa, T | 1 |
| Ishii, H | 1 |
| Takeuchi, H | 1 |
| Kitai, R | 1 |
| Kodera, T | 1 |
| Andersson, U | 1 |
| Grankvist, K | 1 |
| Bergenheim, AT | 1 |
| Behnam-Motlagh, P | 1 |
| Hedman, H | 1 |
| Henriksson, R | 1 |
| Kawase, T | 1 |
| Zhang, RD | 1 |
| Price, JE | 1 |
| Fujimaki, T | 1 |
| Bucana, CD | 1 |
| Fidler, IJ | 1 |
| Knott, JC | 1 |
| Edwards, AJ | 1 |
| Gullan, RW | 1 |
| Clarke, TM | 1 |
| Pilkington, GJ | 1 |
| Murakami, M | 1 |
| Ushio, Y | 1 |
| Mihara, Y | 1 |
| Kuratsu, J | 1 |
| Horiuchi, S | 1 |
| Morino, Y | 1 |
| Neuwelt, EA | 1 |
| Frenkel, EP | 1 |
| D'Agostino, AN | 1 |
| Carney, DN | 1 |
| Minna, JD | 1 |
| Barnett, PA | 1 |
| McCormick, CI | 1 |
| Ginsbourg, M | 2 |
| Foncin, JF | 2 |
| Le Beau, J | 2 |
| Sanders, MD | 1 |
| Piovanetti, E | 1 |
| Eckelhoff, R | 1 |
| Haining, WM | 1 |
| Gass, JD | 1 |
| Feindel, W | 1 |
| Yamamoto, YL | 1 |
| Hodge, CP | 1 |
| Wilcke, O | 2 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase II Study of Eribulin in Brain Metastases From HER2-negative Breast Cancer Pre-treated With Anthracyclines and Taxanes[NCT03637868] | Phase 2 | 0 participants (Actual) | Interventional | 2019-02-26 | Withdrawn (stopped due to no enrollment) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for erythrosine and Brain Neoplasms
| Article | Year |
|---|---|
[RADIOACTIVE ISOTOPES IN THE NEUROLOGICAL DIAGNOSIS].
Topics: Arsenic; Bismuth; Boron; Brain Neoplasms; Copper; Fluoresceins; Fluorine; Humans; Iodine Isotopes; M | 1963 |
1 trial available for erythrosine and Brain Neoplasms
| Article | Year |
|---|---|
Pharmacokinetics of 5-aminofluorescein-albumin, a novel fluorescence marker of brain tumors during surgery.
Topics: Aged; Brain Neoplasms; Chromatography, Gel; Chromatography, High Pressure Liquid; Female; Fluorescei | 2011 |
29 other studies available for erythrosine and Brain Neoplasms
| Article | Year |
|---|---|
Could Fluorescein Staining in Low-Grade Glial Tumors Guide for Peroperative Differentiation of Pathological Types?
Topics: Astrocytoma; Brain Neoplasms; Fluoresceins; Glioblastoma; Glioma; Humans; Oligodendroglioma; Retrosp | 2023 |
Connexin43 confers Temozolomide resistance in human glioma cells by modulating the mitochondrial apoptosis pathway.
Topics: Analysis of Variance; Annexin A5; Antineoplastic Agents, Alkylating; Apoptosis; Brain Neoplasms; Cel | 2013 |
Temozolomide competes for P-glycoprotein and contributes to chemoresistance in glioblastoma cells.
Topics: Animals; Antineoplastic Agents, Alkylating; ATP Binding Cassette Transporter, Subfamily B; Binding, | 2015 |
Use of Labelled tLyP-1 as a Novel Ligand Targeting the NRP Receptor to Image Glioma.
Topics: Amino Acid Sequence; Animals; Brain; Brain Neoplasms; Cell Line, Tumor; Female; Fluoresceins; Fluori | 2015 |
Intraoperative fluorescence staining of malignant brain tumors using 5-aminofluorescein-labeled albumin.
Topics: Adult; Aged; Brain Neoplasms; Cell Proliferation; Female; Fluoresceins; Glioblastoma; Glioma; Humans | 2009 |
Evidence for label-retaining tumour-initiating cells in human glioblastoma.
Topics: Animals; Antigens, CD; Astrocytes; Brain Neoplasms; Cell Cycle; Cell Cycle Proteins; Cell Differenti | 2011 |
Identification and isolation of slow-dividing cells in human glioblastoma using carboxy fluorescein succinimidyl ester (CFSE).
Topics: Brain Neoplasms; Cell Growth Processes; Flow Cytometry; Fluoresceins; Fluorescent Dyes; Glioblastoma | 2012 |
Localization of intracranial neoplasms with radioactive isotopes.
Topics: Brain; Brain Neoplasms; Fluoresceins; Radioisotopes | 1954 |
[Studies on chrome alum hematoxylin-phloxine positive substances in the hypothalumus in intracranial tumor].
Topics: Brain Neoplasms; Coloring Agents; Fluoresceins; Hematoxylin; Humans; Hypothalamus; Staining and Labe | 1962 |
[ON SELECTION OF THE DOSE OF RADIOACTIVE INDICATOR IN RADIOISOTOPE DIAGNOSIS OF BRAIN TUMORS].
Topics: Brain Neoplasms; Diagnostic Techniques, Radioisotope; Fluoresceins; Iodine Isotopes; Radioactivity; | 1963 |
Acyl-based anandamide uptake inhibitors cause rapid toxicity to C6 glioma cells at pharmacologically relevant concentrations.
Topics: Acylation; Animals; Antineoplastic Agents; Arachidonic Acids; Benzyl Compounds; Brain; Brain Neoplas | 2006 |
[Experimental study on the application of argon laser photoactivation effect in the treatment of brain tumor].
Topics: Animals; Argon; Brain Neoplasms; Cells, Cultured; Fibrosarcoma; Fluoresceins; Glioma; Humans; Laser | 1983 |
[Results of fluorescein nose endoscopy in the diagnosis of cerebrospinal rhinorrhea].
Topics: Brain Injuries; Brain Neoplasms; Cerebrospinal Fluid Rhinorrhea; Diagnosis, Differential; Endoscopy; | 1984 |
Experimental and clinical study of detection of glioma at surgery using fluorescent imaging by a surgical microscope after fluorescein administration.
Topics: Animals; Astrocytoma; Brain Neoplasms; Female; Fluorescein; Fluoresceins; Fluorescent Dyes; Glioblas | 1997 |
Rapid induction of long-lasting drug efflux activity in brain vascular endothelial cells but not malignant glioma following irradiation.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily | 2002 |
[Study of cerebral microcirculation by serial fluorescein cortical angiography. (Part 2) Pathology and classification of microcirculation].
Topics: Adult; Aged; Brain Neoplasms; Cerebrovascular Circulation; Female; Fluoresceins; Glioblastoma; Gliom | 1977 |
Differential permeability of the blood-brain barrier in experimental brain metastases produced by human neoplasms implanted into nude mice.
Topics: Animals; Blood-Brain Barrier; Brain Neoplasms; Breast Neoplasms; Cell Membrane; Cell Membrane Permea | 1992 |
A human glioma cell line retaining expression of GFAP and gangliosides, recognized by A2B5 and LB1 antibodies, after prolonged passage.
Topics: Antibodies, Monoclonal; Astrocytes; Brain Neoplasms; Cell Differentiation; Cell Line; Chromosomes, H | 1990 |
Cholesterol uptake by human glioma cells via receptor-mediated endocytosis of low-density lipoprotein.
Topics: Brain Neoplasms; Carbocyanines; Cholesterol, LDL; Endocytosis; Fluorescein-5-isothiocyanate; Fluores | 1990 |
Growth of human lung tumor in the brain of the nude rat as a model to evaluate antitumor agent delivery across the blood-brain barrier.
Topics: Animals; Antineoplastic Agents; Blood-Brain Barrier; Brain Neoplasms; Carcinoma, Small Cell; Cell Li | 1985 |
[Studies on the blood-brain barrier with a fluorescent tracer in human brain edema].
Topics: Animals; Blood-Brain Barrier; Brain Damage, Chronic; Brain Edema; Brain Injuries; Brain Neoplasms; F | 1970 |
[Vascular abnormalities in cerebral tumours. A comparative study of enzyme activity and permeability to fluorescent tracers].
Topics: Adenosine Triphosphatases; Alkaline Phosphatase; Astrocytoma; Blood-Brain Barrier; Brain Neoplasms; | 1973 |
The Foster Kennedy sign.
Topics: Angiography; Brain Neoplasms; Fluoresceins; Frontal Lobe; Fundus Oculi; Humans; Optic Atrophy; Papil | 1972 |
Microcirculatory changes during the evolution of papilledema. A five-stage fluorescein angiographic study of progressive swelling of optic disk in intractable intracranial hypertension.
Topics: Adult; Brain Neoplasms; Capillaries; Fluoresceins; Fundus Oculi; Humans; Male; Melanoma; Microcircul | 1972 |
Diagnostic value of intravenous fluorescein studies.
Topics: Adolescent; Adult; Brain Neoplasms; Diagnosis, Differential; Dye Dilution Technique; Female; Fluores | 1966 |
Cavernous hemangioma of the retina. A neuro-oculo-cutaneous syndrome.
Topics: Adolescent; Adult; Brain Neoplasms; Child; Child, Preschool; Eye Neoplasms; Female; Fluoresceins; Fu | 1971 |
Red cerebral veins and the cerebral steal syndrome. Evidence from fluorescein angiography and microregional blood flow by radioisotopes during excision of an angioma.
Topics: Arteriovenous Malformations; Blood Circulation Time; Blood Gas Analysis; Brain Neoplasms; Carbon Dio | 1971 |
[Scintigraphy of brain tumors].
Topics: Albumins; Antifibrinolytic Agents; Arsenic; Bismuth; Brain Neoplasms; Copper; Fluoresceins; Gallium; | 1965 |
[Isotope diagnosis in neurosurgery].
Topics: Arsenic; Bismuth; Brain Diseases; Brain Neoplasms; Cerebral Hemorrhage; Cerebrovascular Circulation; | 1966 |